KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Bortezomib, a therapeutic agent for multiple myeloma (MM) and mantle cell lymphoma, suppresses proteosomal degradation leading to substantial changes in cellular transcriptional programs and ultimately resulting in apoptosis. Transcriptional regulators required for bortezomib-induced apoptosis in MM...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mannava, Sudha, Zhuang, DaZhong, Nair, Jayakumar R., Bansal, Rajat, Wawrzyniak, Joseph A., Zucker, Shoshanna N., Fink, Emily E., Moparthy, Kalyana C., Hu, Qiang, Liu, Song, Boise, Lawrence H., Lee, Kelvin P., Nikiforov, Mikhail A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2012
Gaiak:
Lymphoid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286209/
https://ncbi.nlm.nih.gov/pubmed/22144178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-346676
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak